PUBLISHER: Lucintel | PRODUCT CODE: 1456031
PUBLISHER: Lucintel | PRODUCT CODE: 1456031
Pharmacovigilance Trends and Forecast
The future of the global pharmacovigilance market looks promising with opportunities in the pharmaceutical, biotechnology company, and medical device manufacturer markets. The global pharmacovigilance market is expected to reach an estimated $10.2 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing demand for safe and effective drugs, growing incidences of adverse drug reactions and drug toxicity, and rising prevalence of chronic diseases.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pharmacovigilance by Segment
The study includes a forecast for the global pharmacovigilance by therapeutic area, process flow, service provider, end use, and region.
List of Pharmacovigilance Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmacovigilance companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmacovigilance companies profiled in this report include-
Pharmacovigilance Market Insights
Lucintel forecasts that oncology will remain the largest segment over the forecast period due to growing number of research activities carried out by different biopharmaceutical companies in the field of cancer treatment.
Within this market, pharmaceutical will remain the largest segment as pharmacovigilance facilitates consumer confidence by enabling them to participate effectively in the reporting of adverse drug reactions.
North America will remain the largest region over the forecast period due to growing cases of drug abuse and existence of major players in the region.
Features of the Global Pharmacovigilance Market
Market Size Estimates: Pharmacovigilance market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pharmacovigilance market size by various segments, such as by therapeutic area, process flow, service provider, end use, and region in terms of value ($B).
Regional Analysis: Pharmacovigilance market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different therapeutic areas, process flow, service provider, end uses, and regions for the pharmacovigilance market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pharmacovigilance market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the pharmacovigilance market size?
Answer: The global pharmacovigilance market is expected to reach an estimated $10.2 billion by 2030.
Q2. What is the growth forecast for pharmacovigilance market?
Answer: The global pharmacovigilance market is expected to grow with a CAGR of 6.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the pharmacovigilance market?
Answer: The major drivers for this market are increasing demand for safe and effective drugs, growing incidences of adverse drug reactions and drug toxicity, and rising prevalence of chronic diseases.
Q4. What are the major segments for pharmacovigilance market?
Answer: The future of the pharmacovigilance market looks promising with opportunities in the pharmaceutical, biotechnology company, and medical device manufacturer markets.
Q5. Who are the key pharmacovigilance market companies?
Answer: Some of the key pharmacovigilance companies are as follows:
Q6. Which pharmacovigilance market segment will be the largest in future?
Answer: Lucintel forecasts that oncology will remain the largest segment over the forecast period due to growing number of research activities carried out by different biopharmaceutical companies in the field of cancer treatment.
Q7. In pharmacovigilance market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing cases of drug abuse and existence of major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.